Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1998
10/08/1998CA2284597A1 Novel pyridine derivatives and pharmaceutical compositions containing them
10/08/1998CA2283097A1 Use of inhibitors of undecaprenol kinase to inhibit cell wall biosynthesis
10/08/1998CA2282593A1 Indazoles of cyclic ureas useful as hiv protease inhibitors
10/08/1998CA2281903A1 Antisense oligonucleotides for mitogen-activated protein kinases as therapy for breast cancer
10/08/1998CA2281875A1 Azole compounds, their production and their use
10/08/1998CA2250106A1 Drug preferably for inhibiting inflammation
10/08/1998CA2234025A1 Novel compounds with pharmaceutical properties
10/08/1998CA2227932A1 Gene encoding invasion protein of campylobacter jejuni
10/07/1998EP0869178A1 SAF-3, Sialoadhesin family member-3
10/07/1998EP0869132A1 "Steroid compounds having contraceptive and anti-osteoporosis activity"
10/07/1998EP0869131A1 5-halo-5-deoxy sorbopyranose compounds
10/07/1998EP0869126A1 Dithiolan derivatives, their preparation and their therapeutic effect
10/07/1998EP0869124A1 Benzamide derivative, anti-ulcer drug, and antibacterial drug
10/07/1998EP0869122A1 Quinolinic sulfide derivatives acting as NMDA receptor antagonists and process for preparation thereof
10/07/1998EP0869121A1 Hypolipidemic propanol amine derivates
10/07/1998EP0869119A1 Phenoxymethyl piperidine derivatives being sodium channle blockers
10/07/1998EP0869118A1 Pyrrolidine derivative, anti-ulcer drug, and antibacterial drug
10/07/1998EP0869116A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent as well as medicaments containing them
10/07/1998EP0869115A2 Amino acid derivatives and compositions containing the same for inhibiting active-oxygen
10/07/1998EP0868919A2 Aqueous suspension of loteprednol etabonate
10/07/1998EP0868916A2 Reduction inhibitory agent for active-oxygen eliminating activity
10/07/1998EP0868915A1 An anti-spasmodic and antiinflammatory composition containing a NSAID, pentifenone and fenpiverinium
10/07/1998EP0868914A1 Pharmaceutical composition for the control and treatment of anorectal and colonic diseases
10/07/1998EP0868911A2 Rapamycin formulations for oral administration
10/07/1998EP0868907A2 Constitutive part of a skin-care product
10/07/1998EP0868716A1 Method for recovering data from disk with magneto-resistive head in presence of thermal asperities
10/07/1998EP0868532A1 METHODS FOR DETERMINING COMPOUNDS CAPABLE OF INHIBITING THE ACTIVITIES OF THE Ha-ras ONCOGENE
10/07/1998EP0868522A1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them
10/07/1998EP0868521A2 Globins containing binding domains
10/07/1998EP0868519A1 Diagnosis and treatment of aur-1 and/or aur-2 related disorders
10/07/1998EP0868518A1 Staphylococcus aureus coenzyme a disulfide reductase, and inhibitors thereof useful as antimicrobial agents
10/07/1998EP0868516A1 Novel tcts response regulator of staphylococcus aureus
10/07/1998EP0868513A1 TGF$g(b) SIGNAL TRANSDUCTION PROTEINS, GENES, AND USES RELATED THERETO
10/07/1998EP0868512A2 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer
10/07/1998EP0868511A1 Utrophin gene expression
10/07/1998EP0868434A1 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs
10/07/1998EP0868433A1 Identification of antigenes from post-infection nematodes for the purpose of developing new anthelmintics and vaccines
10/07/1998EP0868430A1 Therapeutic compositions
10/07/1998EP0868429A1 Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
10/07/1998EP0868428A1 Phosphonic acid derivatives with metallopeptidase inhibitory activity
10/07/1998EP0868425A1 Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments
10/07/1998EP0868424A1 4-pyrimidinyl- or 4-pyrazinyl-piperazinyl-phenyl-oxazolidinone derivatives, their preparation and their use as anti-bacterial agents
10/07/1998EP0868423A1 Method for the synthesis of a benzimidazole compound
10/07/1998EP0868422A1 Ultramicroemulsion of spontaneously dispersible concentrates of esters of baccatin-iii compounds with antitumor and antiviral effect
10/07/1998EP0868420A1 3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity
10/07/1998EP0868196A1 Synthetic vaccine for protection against human immunodeficiency virus infection
10/07/1998EP0868195A2 Control of protein synthesis, and screening method for agents
10/07/1998EP0868194A1 Combination of g-csf with a chemotherapeutic agent for stem cell mobilisation
10/07/1998EP0868192A1 Fast drying, film forming iodine release solution
10/07/1998EP0868191A1 Potentiation of complement and coagulation inhibitory properties of c1-inhibitor.
10/07/1998EP0868190A1 Phospholipid and propylene glycol based lubricant
10/07/1998EP0868189A1 Antineoplastic methods and compositions employing (+)-fotemustine
10/07/1998EP0868188A2 Contraceptive process and kit for female mammals, comprising a combination of gestagen and oestrogen
10/07/1998EP0868187A1 Transdermal estradiol/progestogen agent patch and its production
10/07/1998EP0868186A1 Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia
10/07/1998EP0868185A1 Method for treating depression
10/07/1998EP0868184A1 Sustained-release microgranules containing diltiazem as the active principle
10/07/1998EP0868183A1 Injectable quinolone formulations
10/07/1998EP0868182A1 Process for production of piperidine derivatives
10/07/1998EP0868181A1 USE OF $g(a),$g(a)-DIPHENYLACETIC ACID-4-(N-METHYL-PIPERIDYL)ESTER AS ANTI-SPASMODIC
10/07/1998EP0868180A1 Endothelin receptor antagonists
10/07/1998EP0868179A1 New use for losartan
10/07/1998EP0868178A1 Antagonists of gonadotropin releasing hormone
10/07/1998EP0868177A1 Drug delivery device
10/07/1998EP0868176A1 Aminoguanidine for treating niddm
10/07/1998EP0868175A1 Nitric oxide (no) synthase inhibitor to treat or prevent type ii diabetes
10/07/1998EP0868174A1 Oral gel capsule formulation of 1,2,4-benzotriazine oxides
10/07/1998EP0868170A1 Composition base for topical therapeutic and cosmetic preparations
10/07/1998EP0853627A4 Substituted liposaccharides useful in the treatment and prevention of endotoxemia
10/07/1998EP0837875A4 Inhibitors of farnesyl-protein transferase
10/07/1998EP0807115A4 High molecular weight polymer-based prodrugs
10/07/1998EP0804147B1 Dermato-cosmetologic composition
10/07/1998EP0724566B1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation
10/07/1998EP0720598B1 Phenoxyphenyl cyclopentenyl hydroxyureas
10/07/1998EP0712311B1 Antiglucocorticoid steroids for the treatment of anxiety disorders
10/07/1998EP0711271B1 Aminoindanes and related compounds useful as calcium-channel antagonists
10/07/1998EP0708771B1 Benzyloxyquinuclidines as substance p antagonists
10/07/1998EP0701440A4 Tri(platinum) complexes
10/07/1998EP0700282B1 Inhibition of hair growth
10/07/1998EP0662948B1 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity
10/07/1998EP0649424B1 Dioxcyclobutene derivatives as angiotensin ii antagonists
10/07/1998EP0625044B1 Compositions for nasal administration containing polar metabolites of opioid analgesics
10/07/1998EP0616524B1 Medicaments
10/07/1998EP0558487B1 Piperidine compounds, their preparation and use
10/07/1998CN2293327Y Ointment applied on inner intestine
10/07/1998CN1195354A New thrombin inhibitors their preparation and use
10/07/1998CN1195353A New inhibitors of platelet aggregation
10/07/1998CN1195350A Chemical compounds
10/07/1998CN1195349A Cyclic GMP-specific phosphodiesterase inhibitors
10/07/1998CN1195348A New oxazolidinone derivatives, process for preparing same and medicaments contain these compounds
10/07/1998CN1195346A Preparation of triazoles by organometallic addition to ketones and intermediates therefor
10/07/1998CN1195345A Fungicidal pyrimidinones
10/07/1998CN1195344A Polycyclic alcaloid-derivatives as NMDA-receptor antagonists
10/07/1998CN1195340A Inhibitors of farnesyl-protein transferase
10/07/1998CN1195295A Method and use of connective tissue growth factor as revellent
10/07/1998CN1195294A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligang antibodies, as therapeutic agents for treatment of immunological disease
10/07/1998CN1195291A Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
10/07/1998CN1195290A Use of CGMP-phosphodiesterase inhibitors to treat impotence
10/07/1998CN1195289A Pharmaceutical compositions
10/07/1998CN1195288A Use of fluconazole for inhibiting growth of cancers